Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
CNBC
CNBC
MarketWatch
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.